Contact
/
Home
/
About
Team
Portfolio
Exit History
News
About
Team
Portfolio
Exit History
News
Advent Life Sciences
Advent Life Sciences
Page 1 of 16
<< Start
< Prev
1
2
3
4
5
6
7
8
9
10
Next >
End >>
05.10.2018
Axonics Modulation Technologies, Inc. Announces Pricing of Initial Public Offering of Common Stock
Press Release
15.10.2018
Aravive Biologics and Versartis Complete Merger
Press Release
29.08.2018
KaNDy Therapeutics successfully raises £25 million in a Series C financing
Press Release
24.05.2018
Iterum Therapeutics Announces Pricing of Initial Public Offering
Press Release
22.12.2017
Aura Biosciences Completes $30 Million Series C Financing
Press Release
26.10.2017
Acutus Medical® Receives FDA Clearance for Advanced Cardiac Mapping Technology for Complex Arrhythmias
Press Release
28.09.2017
NeRRe Therapeutics appoints Andrew Kay as Chairman of the Board
Press Release
27.09.2017
KaNDy Therapeutics launched to advance a breakthrough treatment in Women's Health
Press Release
10.05.2017
Iterum Secures $65 Million in Series B Financing
Press Release
03.05.2017
Axonics Announces $14.5 Million First Close of Series C Financing
Press Release
©2019 Advent Life Sciences